DOCSLIB.ORG

Recruitment Via a CCL1 Dependent Pathway Statins Induce Regulatory

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Recruitment Via a CCL1 Dependent Pathway Statins Induce Regulatory Statins Induce Regulatory T Cell Recruitment via a CCL1 Dependent Pathway Emilia Mira, Beatriz León, Domingo F. Barber, Sonia Jiménez-Baranda, Iñigo Goya, Luis Almonacid, Gabriel This information is current as Márquez, Angel Zaballos, Carlos Martínez-A., Jens V. Stein, of September 26, 2021. Carlos Ardavín and Santos Mañes J Immunol 2008; 181:3524-3534; ; doi: 10.4049/jimmunol.181.5.3524 http://www.jimmunol.org/content/181/5/3524 Downloaded from References This article cites 52 articles, 27 of which you can access for free at: http://www.jimmunol.org/content/181/5/3524.full#ref-list-1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication by guest on September 26, 2021 *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2008 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Statins Induce Regulatory T Cell Recruitment via a CCL1 Dependent Pathway1 Emilia Mira,* Beatriz Leo´n,* Domingo F. Barber,* Sonia Jime´nez-Baranda,* In˜igo Goya,* Luis Almonacid,* Gabriel Ma´rquez,† Angel Zaballos,* Carlos Martı´nez-A.,* Jens V. Stein,‡ Carlos Ardavı´n,* and Santos Man˜es2* The statins, a group of inhibitors of the 3-hydroxy-3-methylglutaryl coenzyme A reductase, are reported to influence a variety of immune system activities through 3-hydroxy-3-methylglutaryl coenzyme A reductase-dependent and -independent mechanisms. How statin treatment regulates immune system function in vivo nonetheless remains to be fully defined. We analyzed the immu- nomodulatory effects of lovastatin in a Candida albicans-induced delayed-type hypersensitivity reaction in mice. In this model, lovastatin administration reduced the acute inflammatory response elicited by C. albicans challenge. This anti-inflammatory activity of lovastatin was associated with a shift from a Th1 to a Th2 immune response, as well as an increase in the percentage Downloaded from of regulatory T cells at the inflammation site and in the regional draining lymph node. The lovastatin-induced increase in regulatory T cells in the inflamed skin was dependent on expression of CCL1, a chemokine that is locally up-regulated by statin administration. The anti-inflammatory effect of lovastatin was abrogated in CCL1-deficient mice. These results suggest that local regulation of chemokine expression may be an important process in statin-induced modulation of the immune system. The Journal of Immunology, 2008, 181: 3524–3534. http://www.jimmunol.org/ he statins are used extensively in medical practice be- mokines, master cytokines for T cell polarization, metallopro- cause of their ability to reduce cardiovascular mortality teases, and costimulatory and MHC molecules (reviewed in Refs. T and stroke (1). Although this protective activity was ini- 16 and 17). At high in vitro concentrations, statins might interfere tially ascribed to inhibition of cholesterol biosynthesis, it is now with lymphocyte function by altering signaling in cholesterol-en- evident that statins are pleiotropic drugs with immunomodulatory riched lipid rafts (18, 19). and anti-inflammatory properties. Studies in animal models, as Statins are also reported to induce immunomodulation by 3-hy- well as epidemiological and small-scale clinical trials, suggest that droxy-3-methylglutaryl coenzyme A reductase-independent mech- ␤ statin pleiotropism might be clinically relevant in other patholo- anisms. Several statins bind to the 2 integrin LFA-1, preventing by guest on September 26, 2021 gies, including infection and sepsis (2–5), autoimmunity (6–9), its interaction with the ICAM-1 (20). Statin blockade of the LFA- and organ transplantation (10, 11). 1/ICAM-1 interaction has functional implications in T cell activa- The immunomodulatory effect of statins is thought to involve tion, leukocyte diapedesis, and HIV-1 infection (20–22). several mechanisms that act on different cell types (6, 12, 13). The extent to which each of these pleiotropic activities of statins Statins not only prevent de novo synthesis of cholesterol, they also contributes to immunomodulation in vivo is not well understood. decrease the pool of intermediate isoprenoid metabolites, such as Moreover, the reported immunomodulatory activities of statins farnesyl pyrophosphate or geranylgeranyl pyrophosphate, thus af- would be expected to attenuate the immune response. Paradoxi- fecting GTP-binding signaling proteins, including Ras and Rho- cally, the capacity to mount protective immune responses to intra- GTPases (2, 14, 15). Impairment of GTPase function allows statins cellular pathogens is not diminished in statin-treated patients. In- to affect actin-based cytoskeletal remodeling, cell motility, and the deed, regular statin use has been associated with reduced risk of activity of transcription factors that control the expression of che- bacteremia and sepsis (4, 5), as well as lower incidence and pro- gression of specific cancer types (23). We analyzed the in vivo effect of lovastatin in a murine model *Department of Immunology and Oncology, Centro Nacional de Biotecnologı´a/Con- of skin delayed-type hypersensitivity (DTH)3 response to heat- † sejo Superior de Investigaciones Cientificas (CSIC), Madrid, Spain; Genetrix, Ma- inactivated Candida albicans. Skin DTH responses involve Ag drid, Spain; and ‡Theodor Kocher Institute, University of Bern, Bern, Switzerland uptake, processing, and transport by APC to tissue-draining lymph Received for publication February 29, 2008. Accepted for publication June 20, 2008. nodes, where Ag-specific T cells are triggered to initiate a primary The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance immune response. Secondary exposure to the Ag results in a robust with 18 U.S.C. Section 1734 solely to indicate this fact. local inflammatory response. The coordinated cell and cytokine 1 This work was supported in part by the Spanish Ministry of Education and Science responses required to induce DTH make this experimental system (SAF2005-00241 and NAN2004-08805-C04/04 to S.M.; SAF2006-07609 to C.A.), ideal for in vivo analysis of the immune response. Fundacio´n para la Investigacio´n y Prevencio´n del SIDA en Espan˜a (36550/06 to S.M.), La Marato TV3 Foundation (to S.M.), the Comunidad de Madrid (DIFHE- Our data show that lovastatin reduced the inflammatory re- MAT-CM S-SAL-0304-2006 to S.M. and C.A.), and the European Union FP6 sponse to secondary Ag exposure, and that this effect was not a (INNOCHEM, FP6 LSHB-CT-2005-518167 to S.M. and C.M.A.). The Department of Immunology and Oncology was founded and is supported by the Spanish National Research Council and by Pfizer. 3 Abbreviations used in this paper: DTH, delayed-type hypersensitivity; Ct, cycle 2 Address correspondence and reprint requests to Dr. Santos Man˜es, Department of threshold; DC, dendritic cell; PO-LN, popliteal lymph node; SLO, secondary lym- Immunology and Oncology, Centro Nacional de Biotecnologı´a/Spanish National Re- phoid organs; Treg, regulatory T; WT, wild type. search Council, Darwin 3, Madrid E-28049 Spain. E-mail address: smanes@ cnb.csic.es Copyright © 2008 by The American Association of Immunologists, Inc. 0022-1767/08/$2.00 www.jimmunol.org The Journal of Immunology 3525 Table I. Changes in mRNA levels in the whole footpad after A 4.4 Kb 4.4 Kb C. albicans challenge of lovastatin- and vehicle-treated mice 6.4 Kb SacI SacI BamHI SphI NcoI NcoI BamHI SacI Lovastatin Lovastatin/Vehicle CCL1 WT SphI Molecule (2Ϫ⌬⌬Ct)a Vehicle (2Ϫ⌬⌬Ct)a Ratiob gene P E1 I1 E2 I2 E3 Probe A Probe B IL-1␣ 2.8 Ϯ 0.4 4.4 Ϯ 1.1 Ϫ1.6 IL-1␤ 25.7 Ϯ 2.3 146 Ϯ 37 Ϫ5.7 IL-2 1.8 Ϯ 0.4 1.7 Ϯ 0.7 ϩ1.1 IL-3 not detected not detected —– IL-4 4.4 Ϯ 1.4 0.42 Ϯ 0.8 ϩ10.5 NotI TaqI BamHI BamHI NotI IL-5 2.2 Ϯ 0.7 0.06 Ϯ 1.5 ϩ36.7 Targeting Neor E3E2I2 HSV-TK Vector IL-6 25.3 Ϯ 1.9 47.5 Ϯ 10.1 Ϫ1.9 Ϯ Ϯ ϩ SphI IL-7 1.2 0.2 0.5 1.0 2.4 IL-9 not detected not detected —– IL-10 13.5 Ϯ 8.8 2.9 Ϯ 1.0 ϩ4.7 IL-12␣ 3.4 Ϯ 0.6 12.8 Ϯ 5.2 Ϫ4.8 8.8 Kb IL-12␤ not detected not detected —– 4.4 Kb TGF-␤ 3.8 Ϯ 1.2 2.8 Ϯ 0.7 ϩ1.4 SacI BamHI TNF-␣ 17.7 Ϯ 6.3 25.7 Ϯ 7.1 Ϫ1.5 SphI NcoI TaqI BamHI SacI CCL1 KO IFN-␥ 25.0 Ϯ 7.1 100.5 Ϯ 64 Ϫ3.2 r gene Neo E3E2I2 CCL1 14.5 Ϯ 6.5 1.7 Ϯ 2.1 ϩ8.5 Downloaded from Probe A SphI Probe B CCL2 13.7 Ϯ 5.8 9.9 Ϯ 3.3 ϩ1.4 CCL3 51.3 Ϯ 8.2 53.5 Ϯ 19.2 Ϫ1.0 BC CCL4 33.0 Ϯ 9.5 79.0 Ϯ 5.7 Ϫ2.8 5’ Analysis 3’ Analysis b.p. CCL5 8.3 Ϯ 2.4 41.8 Ϯ 14 Ϫ5.0 -/--/- +/+ +/+ +/- +/- 390403 444 Kb 403 404 406 Kb 2036 CCL6 5.6 Ϯ 0.7 3.7 Ϯ 0.7 ϩ1.5 1636 Ϯ Ϯ ϩ 9 9 1018 CCL7 25.7 5.2 14.5 3.3 1.8 8 517 Ϯ Ϯ ϩ 7 8 KO allele CCL9/10 8.2 0.9 4.2 0.9 1.9 7 506 Ϯ Ϯ ϩ 6 http://www.jimmunol.org/ 6 396 CCL11 1.5 0.5 0.7 1.3 2.4 5 344 421 bp Ϯ Ϯ ϩ 4 5 CCL17 3.3 0.5 1.5 0.2 2.2 4 298 3 CCL20 3.7 Ϯ 0.3 4.1 Ϯ 0.6 Ϫ1.1 3 CCL22 3.4 Ϯ 1.8 2.3 Ϯ 1.0 ϩ1.5 2 CCL27 0.5 Ϯ 0.5 0.16 Ϯ 1.9 ϩ3.1 2 2036 1636 CXCL1 6.0 Ϯ 2.0 20.2 Ϯ 1.1 Ϫ3.4 1018 517 WT allele CXCL2 32.2 Ϯ 5.5 186 Ϯ 77.2 Ϫ5.8 1 506 Ϯ Ϯ Ϫ 1 396 604 bp CXCL5 33.5 2.5 274 80.8 8.2 344 CXCL9 14.0 Ϯ 2.0 19.6 Ϯ 1.6 Ϫ1.4 SphI Digestion SacI Digestion 298 CXCL10 28.8 Ϯ 7.2 65.2 Ϯ 4.9 Ϫ2.3 Probe A Probe B CXCL11 26.4 Ϯ 1.1 44.8 Ϯ 12.4 ϩ1.7 FIGURE 1.
Load more

Recommended publications
  • Mouse CD163 Deficiency Strongly Enhances Experimental Collagen-Induced Arthritis
    www.nature.com/scientificreports OPEN Mouse CD163 defciency strongly enhances experimental collagen‑induced arthritis Pia Svendsen1,2, Anders Etzerodt 3, Bent W. Deleuran3,4 & Søren K. Moestrup1,2,5* The scavenger receptor CD163 is highly expressed in macrophages in sites of chronic infammation where it has a not yet defned role. Here we have investigated development of collagen‑induced arthritis (CIA) and collagen antibody‑induced arthritis (CAIA) in CD163‑defcient C57BL/6 mice. Compared to wild‑type mice, the CIA in CD163‑defcient mice had a several‑fold higher arthritis score with early onset, prolonged disease and strongly enhanced progression. Further, the serum anti‑ collagen antibody isotypes as well as the cytokine profles and T cell markers in the infamed joints revealed that CD163‑defcient mice after 52 days had a predominant Th2 response in opposition to a predominant Th1 response in CD163+/+ mice. Less diference in disease severity between the CD163+/+ and CD163−/− mice was seen in the CAIA model that to a large extent induces arthritis independently of T‑cell response and endogenous Th1/Th2 balance. In conclusion, the present set of data points on a novel strong anti‑infammatory role of CD163. Te scavenger receptor CD163 is expressed exclusively in cells of monocytic origin with a high expression in M2-type macrophages where it has an established role in scavenging hemoglobin (Hb) released into plasma 1. Te receptor and its function have been most intensively studied in human systems, but the selective myelomonocytic expression of CD163 with a high upregulation in the M2-type macrophages is also seen in animals including rodents2,3.
    [Show full text]
  • Toxicogenomics Article
    Toxicogenomics Article Discovery of Novel Biomarkers by Microarray Analysis of Peripheral Blood Mononuclear Cell Gene Expression in Benzene-Exposed Workers Matthew S. Forrest,1 Qing Lan,2 Alan E. Hubbard,1 Luoping Zhang,1 Roel Vermeulen,2 Xin Zhao,1 Guilan Li,3 Yen-Ying Wu,1 Min Shen,2 Songnian Yin,3 Stephen J. Chanock,2 Nathaniel Rothman,2 and Martyn T. Smith1 1School of Public Health, University of California, Berkeley, California, USA; 2Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA; 3National Institute of Occupational Health and Poison Control, Chinese Center for Disease Control and Prevention, Beijing, China were then ranked and selected for further exam- Benzene is an industrial chemical and component of gasoline that is an established cause of ination using several forms of statistical analysis. leukemia. To better understand the risk benzene poses, we examined the effect of benzene expo- We also specifically examined the expression sure on peripheral blood mononuclear cell (PBMC) gene expression in a population of shoe- of all cytokine genes on the array under the factory workers with well-characterized occupational exposures using microarrays and real-time a priori hypothesis that these key genes polymerase chain reaction (PCR). PBMC RNA was stabilized in the field and analyzed using a involved in immune function are likely to be comprehensive human array, the U133A/B Affymetrix GeneChip set. A matched analysis of six altered by benzene exposure (Aoyama 1986). exposed–control pairs was performed. A combination of robust multiarray analysis and ordering We then attempted to confirm the array find- of genes using paired t-statistics, along with bootstrapping to control for a 5% familywise error ings for the leading differentially expressed rate, was used to identify differentially expressed genes in a global analysis.
    [Show full text]
  • Complementary DNA Microarray Analysis of Chemokines and Their Receptors in Allergic Rhinitis RX Zhang,1 SQ Yu,2 JZ Jiang,3 GJ Liu3
    RX Zhang, et al ORIGINAL ARTICLE Complementary DNA Microarray Analysis of Chemokines and Their Receptors in Allergic Rhinitis RX Zhang,1 SQ Yu,2 JZ Jiang,3 GJ Liu3 1 Department of Otolaryngology, Huadong Hospital, Fudan University, Shanghai, China 2 Department of Otolaryngology , Jinan General Hospital of PLA, Shandong, China 3 Department of Otolaryngology, Changhai Hospital, Second Military Medical University, Shanghai, China ■ Abstract Objective: To analyze the roles of chemokines and their receptors in the pathogenesis of allergic rhinitis by observing the complementary DNA (cDNA) expression of the chemokines and their receptors in the nasal mucosa of patients with and without allergic rhinitis, using gene chips. Methods: The total RNAs were isolated from the nasal mucosa of 20 allergic rhinitis patients and purifi ed to messenger RNAs, and then reversely transcribed to cDNAs and incorporated with samples of fl uorescence-labeled with Cy5-dUPT (rhinitis patient samples) or Cy3- dUTP (control samples of nonallergic nasal mucosa). Thirty-nine cDNAs of chemokines and their receptors were latticed into expression profi le chips, which were hybridized with probes and then scanned with the computer to study gene expression according to the different fl uorescence intensities. Results: The cDNAs of the following chemokines were upregulated: CCL1, CCL2, CCL5, CCL7, CCL8, CCL11, CCL13, CCL14, CCL17, CCL18, CCL19, CCL24, and CX3CL1 in most of the allergic rhinitis sample chips. CCR2, CCR3, CCR4, CCR5, CCR8 and CX3CR1 were the highly expressed receptor genes. Low expression of CXCL4 was found in these tissues. Conclusion: The T helper cell (TH) immune system is not well regulated in allergic rhinitis.
    [Show full text]
  • CXCL16 Suppresses Liver Metastasis of Colorectal Cancer by Promoting
    Kee et al. BMC Cancer 2014, 14:949 http://www.biomedcentral.com/1471-2407/14/949 RESEARCH ARTICLE Open Access CXCL16 suppresses liver metastasis of colorectal cancer by promoting TNF-α-induced apoptosis by tumor-associated macrophages Ji-Ye Kee1†, Aya Ito1,2†, Shozo Hojo3, Isaya Hashimoto3, Yoshiko Igarashi2, Koichi Tsuneyama4, Kazuhiro Tsukada3, Tatsuro Irimura5, Naotoshi Shibahara2, Ichiro Takasaki9, Akiko Inujima2, Takashi Nakayama6, Osamu Yoshie7, Hiroaki Sakurai8, Ikuo Saiki1 and Keiichi Koizumi2*† Abstract Background: Inhibition of metastasis through upregulation of immune surveillance is a major purpose of chemokine gene therapy. In this study, we focused on a membrane-bound chemokine CXCL16, which has shown a correlation with a good prognosis for colorectal cancer (CRC) patients. Methods: We generated a CXCL16-expressing metastatic CRC cell line and identified changes in TNF and apoptosis- related factors. To investigate the effect of CXCL16 on colorectal liver metastasis, we injected SL4-Cont and SL4-CXCL16 cells into intraportal vein in C57BL/6 mice and evaluated the metastasis. Moreover, we analyzed metastatic liver tissues using flow cytometry whether CXCL16 expression regulates the infiltration of M1 macrophages. Results: CXCL16 expression enhanced TNF-α-induced apoptosis through activation of PARP and the caspase-3- mediated apoptotic pathway and through inactivation of the NF-κB-mediated survival pathway. Several genes were changed by CXCL16 expression, but we focused on IRF8, which is a regulator of apoptosis and the metastatic phenotype. We confirmed CXCL16 expression in SL4-CXCL16 cells and the correlation between CXCL16 and IRF8. Silencing of IRF8 significantly decreased TNF-α-induced apoptosis. Liver metastasis of SL4-CXCL16 cells was also inhibited by TNF-α-induced apoptosis through the induction of M1 macrophages, which released TNF-α.
    [Show full text]
  • Bioinformatics Identification of CCL8/21 As Potential Prognostic
    Bioscience Reports (2020) 40 BSR20202042 https://doi.org/10.1042/BSR20202042 Research Article Bioinformatics identification of CCL8/21 as potential prognostic biomarkers in breast cancer microenvironment 1,* 2,* 3 4 5 1 Bowen Chen , Shuyuan Zhang ,QiuyuLi, Shiting Wu ,HanHe and Jinbo Huang Downloaded from http://portlandpress.com/bioscirep/article-pdf/40/11/BSR20202042/897847/bsr-2020-2042.pdf by guest on 28 September 2021 1Department of Breast Disease, Maoming People’s Hospital, Maoming 525000, China; 2Department of Clinical Laboratory, Maoming People’s Hospital, Maoming 525000, China; 3Department of Emergency, Maoming People’s Hospital, Maoming 525000, China; 4Department of Oncology, Maoming People’s Hospital, Maoming 525000, China; 5Department of Medical Imaging, Maoming People’s Hospital, Maoming 525000, China Correspondence: Shuyuan Zhang ([email protected]) Background: Breast cancer (BC) is the most common malignancy among females world- wide. The tumor microenvironment usually prevents effective lymphocyte activation and infiltration, and suppresses infiltrating effector cells, leading to a failure of the host toreject the tumor. CC chemokines play a significant role in inflammation and infection. Methods: In our study, we analyzed the expression and survival data of CC chemokines in patients with BC using several bioinformatics analyses tools. Results: The mRNA expression of CCL2/3/4/5/7/8/11/17/19/20/22 was remark- ably increased while CCL14/21/23/28 was significantly down-regulated in BC tis- sues compared with normal tissues. Methylation could down-regulate expression of CCL2/5/15/17/19/20/22/23/24/25/26/27 in BC. Low expression of CCL3/4/23 was found to be associated with drug resistance in BC.
    [Show full text]
  • CXC Chemokine Ligand 16 Regulates the Cell Surface Expression of 10
    A Disintegrin and Metalloproteinase 10-Mediated Cleavage and Shedding Regulates the Cell Surface Expression of CXC Chemokine Ligand 16 This information is current as of October 2, 2021. Peter J. Gough, Kyle J. Garton, Paul T. Wille, Marcin Rychlewski, Peter J. Dempsey and Elaine W. Raines J Immunol 2004; 172:3678-3685; ; doi: 10.4049/jimmunol.172.6.3678 http://www.jimmunol.org/content/172/6/3678 Downloaded from References This article cites 35 articles, 18 of which you can access for free at: http://www.jimmunol.org/content/172/6/3678.full#ref-list-1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication by guest on October 2, 2021 *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2004 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology A Disintegrin and Metalloproteinase 10-Mediated Cleavage and Shedding Regulates the Cell Surface Expression of CXC Chemokine Ligand 16 Peter J. Gough,2* Kyle J. Garton,* Paul T.
    [Show full text]
  • US7572600.Pdf
    US007572600B2 (12) United States Patent (10) Patent No.: US 7,572,600 B2 Berahovich et al. (45) Date of Patent: Aug. 11, 2009 (54) ENZYMATIC ACTIVITIES IN WO WO90, 13332 11, 1990 CHEMOKNE-MEDIATED INFLAMMATION WO WO 91/12779 9, 1991 WO WO 91f17271 11, 1991 (75) WO WO91, 1898O 12/1991 Inventors: Robert D. Berahovich, Berkeley, CA WO WO92fO1047 1, 1992 (US); Zhenhua Miao, San Jose, CA WO WO93,06121 4f1993 (US); Brett Premack, San Francisco, WO WO93, 17706 9, 1993 CA (US); Thomas J. Schall, Palo Alto, WO WO93/24640 12/1993 CA (US) WO WO94,08051 4f1994 WO WO94/20142 9, 1994 (73) Assignee: Chemocentryx, Inc., Mt. View, CA (US) WO WO95/12608 5, 1995 WO WO95/30642 11, 1995 (*) Notice: Subject to any disclaimer, the term of this WO WO95/35503 12/1995 patent is extended or adjusted under 35 WO WO 98.04554 2, 1998 U.S.C. 154(b) by 486 days. OTHER PUBLICATIONS (21) Appl. No.: 11/198,935 Al-Obeidi (1998), Mol. Biotechnol. 9:205-223. Aoyama, Y. et al. (2001), Bioorg Med. Chem. Lett. 11: 1691-4. (22) Filed: Aug. 4, 2005 Amour, A., et al. (1998), J. Pharm. Pharmacol. 50:593-600. Berger, M.S. etal (1993), DNA Cell Biol 12:839-847. (65) Prior Publication Data Bao, L., et al. (1992), Genomics 13:437-40. US 2006/OO63223 A1 Mar. 23, 2006 Berman et al. (1988), Immunol. Invest. 17: 625-677. Baici, A. (1993), Biochem. Pharmacol. 46:1545-9. Bae, Y.-S. et al. (2004) J Immunol. 173:607-614.
    [Show full text]
  • Dendritic Cells Maintain Anti-Tumor Immunity by Positioning CD8 Skin-Resident Memory T Cells
    Published Online: 6 August, 2021 | Supp Info: http://doi.org/10.26508/lsa.202101056 Downloaded from life-science-alliance.org on 26 September, 2021 Research Article Dendritic cells maintain anti-tumor immunity by positioning CD8 skin-resident memory T cells Jennifer L Vella1, Aleksey Molodtsov1, Christina V Angeles2 , Bruce R Branchini3, Mary Jo Turk1,4, Yina H Huang1,4,5 Tissue-resident memory (TRM) T cells are emerging as critical maintenance, leading us to determine whether specific accessory components of the immune response to cancer; yet, requirements cells maintain TRM cell homeostasis within a tissue niche. for their ongoing function and maintenance remain unclear. APCs The immune response to solid cancers is limited by availability promote TRM cell differentiation and re-activation but have not of neoantigens, tolerance to self-antigens, T-cell dysfunction, and been implicated in sustaining TRM cell responses. Here, we immunosuppression within the tumor microenvironment. Check- identified a novel role for dendritic cells in supporting TRM to point blockade immunotherapy, which blocks inhibitory receptors melanoma. We showed that CD8 TRM cells remain in close prox- such as PD-1 and CTLA-4, can reverse T-cell dysfunction and when imity to dendritic cells in the skin. Depletion of CD11c+ cells results combined achieves >50% patient responsiveness. However, pre- in rapid disaggregation and eventual loss of melanoma-specific dicting patient responders remains a challenge. Recently, expression TRM cells. In addition, we determined that TRM migration and/or of TRM cell markers in tumor infiltrating lymphocytes has been re- persistence requires chemotaxis and adhesion mediated by the ported to correlate with patient responsiveness and prolonged CXCR6/CXCL16 axis.
    [Show full text]
  • Metastasis: Active Lymph Nodes
    RESEARCH HIGHLIGHTS METASTASIS subcapsular sinus. Further investiga- tions in vivo revealed that CCR8 acti- vation in tumour cells was required Active lymph nodes for tumour cell extravasation from lymphatic vessels, specifically for the Lymph node metastases are CCL1 activates CCR8-mediated transmigration of tumour cells from indicative of poor prognosis but intracellular signalling in tumour the subcapsular sinus into the lymph tumour cell the mechanisms of tumour cell cells, which resulted in cellular node cortex. entry into the dissemination via the lymphatics changes that are consistent with cell These data unpick the process of are poorly understood. Although it migration. lymphatic dissemination and iden- lymph node is widely believed that tumour cells Is the CCR8–CCL1 paracrine tify the sequence of steps leading to requires active enter the lymph nodes passively with pathway important in lymphatic lymph node metastasis. The authors cell migration the flow of lymph, previous data have metastasis? The suppression of showed that CCR8 is expressed by indicated that some chemokines may CCR8 expression or activity in a large subset of human melanoma promote lymphatic extravasation human melanoma cells did not samples, and it will be interesting and metastasis. Das et al. now dem- affect tumour growth or vasculariz­ to determine whether this pathway onstrate that tumour cell entry into ation on implantation into immuno­ can be targeted to prevent lymph the lymph node requires active cell deficient mice, but significantly node metastasis. migration and they also identify the reduced the incidence of lymph Gemma K. Alderton lymphatic endothelium of the lymph node metastasis. Furthermore, ORIGINAL RESEARCH PAPER Das, S.
    [Show full text]
  • Responses During Sepsis Interactions Exacerbate Innate Immune CCR1
    The Journal of Immunology CCR1 and CC Chemokine Ligand 5 Interactions Exacerbate Innate Immune Responses during Sepsis1 Traci L. Ness,* Kristin J. Carpenter,* Jillian L. Ewing,* Craig J. Gerard,† Cory M. Hogaboam,2* and Steven L. Kunkel* CCR1 has previously been shown to play important roles in leukocyte trafficking, pathogen clearance, and the type 1/type 2 cytokine balance, although very little is known about its role in the host response during sepsis. In a cecal ligation and puncture model of septic peritonitis, CCR1-deficient (CCR1؊/؊) mice were significantly protected from the lethal effects of sepsis when compared with wild-type (WT) controls. The peritoneal and systemic cytokine profile in CCR1؊/؊ mice was characterized by a robust, but short-lived and regulated antibacterial response. CCR1 expression was not required for leu- -kocyte recruitment, suggesting critical differences extant in the activation of WT and CCR1؊/؊ resident or recruited peri toneal cells during sepsis. Peritoneal macrophages isolated from naive CCR1؊/؊ mice clearly demonstrated enhanced cytokine/chemokine generation and antibacterial responses compared with similarly treated WT macrophages. CCR1 and CCL5 interactions markedly altered the inflammatory response in vivo and in vitro. Administration of CCL5 increased sepsis-induced lethality in WT mice, whereas neutralization of CCL5 improved survival. CCL5 acted in a CCR1-dependent manner to augment production of IFN-␥ and MIP-2 to damaging levels. These data illustrate that the interaction between CCR1 and CCL5 modulates the innate immune response during sepsis, and both represent potential targets for therapeutic intervention. The Journal of Immunology, 2004, 173: 6938–6948. epsis is the most common cause of death in noncoronary mune response to sepsis (7, 8).
    [Show full text]
  • Retinoid X Receptor Α Controls Innate Inflammatory Responses Through The
    Retinoid X receptor α controls innate inflammatory responses through the up-regulation of chemokine expression Vanessa Núñeza,1, Daniel Alamedaa,1, Daniel Ricoa,2, Rubén Motab, Pilar Gonzalob, Marta Cedenillaa, Thierry Fischerc, Lisardo Boscád, Christopher K. Glasse, Alicia G. Arroyob, and Mercedes Ricotea,3 Departments of aRegenerative Cardiology and bVascular Biology and Inflammation, Centro Nacional de Investigaciones Cardiovasculares, Madrid 28029, Spain; cDepartment of Immunology and Oncology, Centro Nacional de Biotecnología, Madrid 28049, Spain; dInstituto de Investigaciones Biomédicas “Alberto Sols” (CSIC-UAM), Madrid 28029, Spain; and eDepartment of Medicine, Department of Cellular and Molecular Medicine, University of California, La Jolla, CA 92093 Edited* by Daniel Steinberg, University of California, La Jolla, CA, and approved April 19, 2010 (received for review November 25, 2009) The retinoid X receptor α (RXRα) plays a central role in the regulation Chemokines and their receptors have been implicated in the of many intracellular receptor signaling pathways and can mediate modulation of leukocyte trafficking, immune/inflammatory respon- ligand-dependent transcription by forming homodimers or hetero- ses, sepsis, and multiorgan failure (18, 19). Clinical studies have also dimers with other nuclear receptors. Although several members of identified elevated levels of chemokines associated with human the nuclear hormone receptor superfamily have emerged as impor- sepsis and acute lung injury (20). tant regulators of macrophage gene expression, the existence in vivo We have examined the role of RXRα in the innate immune of an RXR signaling pathway in macrophages has not been estab- system by conditionally disrupting RXRα in myeloid cells. We lished. Here, we provide evidence that RXRα regulates the transcrip- show that chemokines Ccl6 and Ccl9 are novel target genes for tion of the chemokines Ccl6 and Ccl9 in macrophages independently RXRα in primary peritoneal macrophages.
    [Show full text]
  • CCL9 Is Secreted by the Follicle-Associated Epithelium and Recruits Dome Region Peyer's Patch Cd11b+ Dendritic Cells
    CCL9 Is Secreted by the Follicle-Associated Epithelium and Recruits Dome Region Peyer's Patch CD11b+ Dendritic Cells This information is current as Xinyan Zhao, Ayuko Sato, Charles S. Dela Cruz, Melissa of October 1, 2021. Linehan, Andreas Luegering, Torsten Kucharzik, Aiko-Konno Shirakawa, Gabriel Marquez, Joshua M. Farber, Ifor Williams and Akiko Iwasaki J Immunol 2003; 171:2797-2803; ; doi: 10.4049/jimmunol.171.6.2797 http://www.jimmunol.org/content/171/6/2797 Downloaded from References This article cites 32 articles, 19 of which you can access for free at: http://www.jimmunol.org/content/171/6/2797.full#ref-list-1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication by guest on October 1, 2021 *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts Errata An erratum has been published regarding this article. Please see next page or: /content/172/11/7220.2.full.pdf The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2003 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology CCL9 Is Secreted by the Follicle-Associated Epithelium and Recruits Dome Region Peyer’s Patch CD11b؉ Dendritic Cells1 Xinyan Zhao,2* Ayuko Sato,* Charles S.
    [Show full text]